March 2007

• Looking for hidden signs of consciousness

  Standfirst

  A 'brain-activity' test for patients in a vegetative state has divided neurologists.

  news@nature.com

  (21 March 2007); doi:10.1038/446355a

• A chip in the eye boosts sight

  Standfirst

  Amplification of light restores limited vision in some damaged retinas.

  news@nature.com

  (21 March 2007); doi:10.1038/news070319-7

• Commonly used anaesthetic alters mouse brains

  Standfirst

  Study adds to concerns over drug link to Alzheimer's.

  news@nature.com

  (12 March 2007); doi:10.1038/news070312-1

• Wipe out a single memory

  Standfirst

  Drug can clear away one fearful memory while leaving another intact.

  news@nature.com

  (11 March 2007); doi:10.1038/news070305-17

• Biobank provides leads for selecting guide dogs

  Standfirst

  Genetics highlights the pick of the pups.

  news@nature.com

  (7 March 2007); doi:10.1038/446119a

• Dozens of new cancer genes found

  Standfirst

  Genome sweep shows cancer-driving mutations more common than thought.

  news@nature.com

  (7 March 2007); doi:10.1038/news070305-7

• Psychological attacks rank high on torture list

  Standfirst

  Watching a sham execution comes near the top of distressing assaults.

  news@nature.com

  (5 March 2007); doi:10.1038/news070305-2

• Meet the human metabolome

  Standfirst

  Can body fluids succeed where genomics and proteomics have failed?

  news@nature.com

  (28 February 2007); doi:10.1038/446008a

• Data sharing: the next generation

  Standfirst

  Social software offers fresh perspectives on results.

  news@nature.com

  (28 February 2007); doi:10.1038/446010b

• A merger too far?

  Standfirst

  Bristol-Myers Squibb has been stoking its research productivity. Meredith Wadman investigates whether an acquisition would be the right prescription for the company.

  news@nature.com

  (28 February 2007); doi:10.1038/446015a

• Cloning special: Dolly: a decade on

  Standfirst

  Ten years ago, the birth of Dolly the sheep sparked a media frenzy and a prolonged ethical debate. Today, the arguments have switched focus to stem cells, and the research itself is beginning to change tack.

  news@nature.com

  (21 February 2007); doi:10.1038/445800a

• Japanese TV show admits faking science

  Standfirst

  Programme makers redubbed interviews and changed experimental results.

  news@nature.com

  (21 February 2007); doi:10.1038/445804a